Table 2 Ophthalmologic assessment.
From: Ocular surface manifestation of COVID-19 and tear film analysis
Distance spectacles, n (%) | 10 (34.5%) |
Previous ocular surgery, n (%) | 8 (27.6%) |
Previous ocular disease, n (%) | 3 (10.3%) |
Patients with ocular symptoms, n (%) | 10 (34.5%) |
SPEED questionnaire | |
Severity | 1.21 ± 0.9 |
Frequency | 1.14 ± 0.8 |
Total | 2.35 ± 1.7 |
Ocular symptoms | |
Foreign body sensation, n (%) | 3 (10.3%) |
Ocular pain, n (%) | 3 (10.3%) |
Dryness, n (%) | 2 (6.9%) |
Tearing, n (%) | 5 (17.2%) |
Ocular findings | |
Hyperemia, n (%) | 7 (24.1%) |
Chemosis, n (%) | 1 (3.4%) |
Secretion, n (%) | 2 (6.9%) |
Lid margin hyperemia, n (%) | 10 (34.5%) |
Crusted eyelashes, n (%) | 7 (24.1%) |
Meibomian orifices abnormalities, n (%) | 6 (20.7%) |
Schirmer I test, mm/5 min | |
Right eye | 9.2 ± 6.4 |
Left eye | 9.3 ± 6.4 |
